2017
TARK advised Icosagen AS and its subsidiary Icosagen Technolohies Inc in a complex transaction which included the exit of one shareholder and the buy-in of two new shareholders. Transaction team consisting of partner Hannes Küün and senior associate Tanel Küün assisted the client by preparing the transaction structure and the transaction documents.
Icosagen Group is a company focused on providing and developing novel biotechnology products, services and researches to biopharmaceutical and biotechnology industries and to academia. The clients of Icosagen Group are based in Estonia, Europe, Asia and in the United States. Icosagen Technologies Inc. was established in 2016, in order to give US customers access to Icosagen’s technologies and services.
